Bienaime Jean Jacques's Form 4 filing
Immunome Inc. (IMNM) · filed Jun 9, 2026
- Accession no.
- 0001221590-26-000015
- Filed
- Jun 9, 2026
- Trade date
- Jun 5, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market purchases total $204.3K. Open-market sales total $203.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bienaime Jean JacquesCIK 0001221590 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | SSaleDisposed | −500 | $19.44 | −$9,720 | 42,915 | Direct | |
| Jun 5, 2026 | Common Stock | SSaleDisposed | −10,000 | $19.41 | −$194,100 | 32,915 | Direct | |
| Jun 5, 2026 | Common Stock | PPurchaseAcquired | +6,000 | $19.48 | +$116,880 | 38,915 | Direct | |
| Jun 5, 2026 | Common Stock | PPurchaseAcquired | +3,500 | $19.46 | +$68,110 | 42,415 | Direct | |
| Jun 5, 2026 | Common Stock | PPurchaseAcquired | +1,000 | $19.27 | +$19,270 | 43,415 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.